Analystreport

ZIOPHARM Oncology Inc. (NASDAQ: ZIOP) was given a new $6.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock.

ZIOPHARM Oncology Inc  (ZIOP) 
Last ziopharm oncology inc earnings: 3/2 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.ziopharm.com